Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has issued an update.
Imricor Medical Systems, Inc. announced a change in the director’s interest as Mr. Mark Tibbles acquired 41,280 Class A common stocks under the company’s Equity Incentive Plan. This acquisition, approved at the AGM on May 14, 2025, increases Mr. Tibbles’ total holdings to 6,272,193 shares, reflecting the company’s ongoing commitment to aligning management interests with shareholder value.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.28 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. operates in the medical technology industry, focusing on developing innovative products for cardiac ablation procedures. The company is known for its MRI-compatible devices, which are designed to improve the safety and efficacy of cardiac ablations.
Average Trading Volume: 417,906
See more data about IMR stock on TipRanks’ Stock Analysis page.